Journal Watch · Nucleic Acids Research · 2026
CRYSPER and CUREIPES: two new molecular tools enabling analysis of RNA splicing and C-to-U RNA editing-inducible protein expression at single cell resolution.
Based on CRYSPER, CUREIPES was developed and is the first molecular tool that enables human Apobec1-dependent C-to-U RNA editing-inducible protein expression, which can be used to counteract pathological alteration of C-to-U RNA editing through cell-autonomous expression of editing-regulatory proteins, or of any other protein of interest.
TL;DR
Based on CRYSPER, CUREIPES was developed and is the first molecular tool that enables human Apobec1-dependent C-to-U RNA editing-inducible protein expression, which can be used to counteract pathological alteration of C-to-U RNA editing through cell-autonomous expression of editing-regulatory proteins, or of any other protein of interest.
Key findings
- Thus, CRYSPER can be the new tool for research on canonical and noncanonical RNA splicing.
- Based on CRYSPER, CUREIPES was developed and is the first molecular tool that enables human Apobec1-dependent C-to-U RNA editing-inducible protein expression, which can be used to counteract pathological alteration of C-to-U RNA editing through cell-autonomous expression of editing-regulatory proteins, or of any other protein of interest.
What they did
They use ratiometric fluorescence analysis for single-cell readout of RNA processing. Using CRYSPER, the results show noncanonical splice site usage in different cell types and demonstrate that the second intronic position can be a wobble base. Cellular heterogeneity of cryptic splice site utilization indicates cell type-specific control of this type of RNA processing and reveal a novel dimension of the regulation of RNA splicing.
Full abstract (original)
Background: RNA splicing and editing contribute to functional diversification of proteins encoded by single genes. Previous and current research primarily focus on sequencing of bulk material and bioinformatics to identify editing and splice sites, but these technologies ignore the role of individual cell types in the regulation of RNA splicing and editing. We present two new molecular tools for analysis of canonical and noncanonical RNA splicing (CRYSPER) and human Apobec1-dependent C-to-U RNA editing-inducible protein expression (CUREIPES).
What they did: They use ratiometric fluorescence analysis for single-cell readout of RNA processing. Using CRYSPER, the results show noncanonical splice site usage in different cell types and demonstrate that the second intronic position can be a wobble base. Cellular heterogeneity of cryptic splice site utilization indicates cell type-specific control of this type of RNA processing and reveal a novel dimension of the regulation of RNA splicing.
Results & conclusions: Thus, CRYSPER can be the new tool for research on canonical and noncanonical RNA splicing. Based on CRYSPER, CUREIPES was developed and is the first molecular tool that enables human Apobec1-dependent C-to-U RNA editing-inducible protein expression, which can be used to counteract pathological alteration of C-to-U RNA editing through cell-autonomous expression of editing-regulatory proteins, or of any other protein of interest.
Abstract © the authors / Nucleic Acids Research (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1093/nar/gkag899 · PubMed 42779099.
Why it matters for pharma & biotech
- Relevant to Biology & Life Sciences teams tracking Nucleic Acids Research for new targets, mechanisms and biomarkers.
- As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
- For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.
Limitations & what to check in the full text
- This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
- The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.
Frequently asked questions
What did this Nucleic Acids Research study find?
Based on CRYSPER, CUREIPES was developed and is the first molecular tool that enables human Apobec1-dependent C-to-U RNA editing-inducible protein expression, which can be used to counteract pathological alteration of C-to-U RNA editing through cell-autonomous expression of editing-regulatory proteins, or of any other protein of interest.
What type of study is this?
It is a genomics / omics study, published in Nucleic Acids Research in 2026. They use ratiometric fluorescence analysis for single-cell readout of RNA processing.
Where can I read the original paper?
The original is at the publisher via DOI 10.1093/nar/gkag899. PubMed ID: 42779099. BioStudioAI reproduces the abstract for discussion and links to the source.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/crysper-and-cureipes-two-new-molecular-tools-enabling-analysis-of-rna-sp-kag899/
Reading papers is step one. Analysing the data is the work.
BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.
Open BioStudioAI More guides